In the latest trading session, 4.13 million SILO Pharma Inc (NASDAQ:SILO) shares changed hands as the company’s beta touched 0. With the company’s most recent per share price at $1.64 changing hands around $0.01 or 0.65% at last look, the market valuation stands at $5.10M. SILO’s current price is a discount, trading about -300.0% off its 52-week high of $6.56. The share price had its 52-week low at $1.22, which suggests the last value was 25.61% up since then. When we look at SILO Pharma Inc’s average trading volume, we note the 10-day average is 8170.0 shares, with the 3-month average coming to 21.65K.
Analysts gave the SILO Pharma Inc (SILO) stock a consensus recommendation rating of a Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended SILO as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. SILO Pharma Inc’s EPS for the current quarter is expected to be $0.
SILO Pharma Inc (NASDAQ:SILO) trade information
Instantly SILO is in green as seen in intraday trades today. With action 26.15%, the performance over the past five days has been green. The jump to weekly highs of 1.9800 on Monday, 11/20/23 added 0.65% to the stock’s daily price. The company’s shares are showing year-to-date downside of -51.19%, with the 5-day performance at 26.15% in the green. However, in the 30-day time frame, SILO Pharma Inc (NASDAQ:SILO) is 20.58% up. Looking at the short shares, we see there were 56720.0 shares sold at short interest cover period of 2.36 days.
SILO Pharma Inc is expected to release its next quarterly earnings report on November 13.
SILO Pharma Inc (NASDAQ:SILO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 14.83% of SILO Pharma Inc shares while 2.76% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 3.24%. There are 2.76% institutions holding the SILO Pharma Inc stock share, with Financial Advocates Investment Management the top institutional holder. As of Jun 29, 2023, the company held 0.06% of the shares, roughly 57507.0 SILO shares worth $0.12 million.
Geode Capital Management, LLC holds the second largest percentage of outstanding shares, with 0.02% or 24542.0 shares worth $50311.0 as of Jun 29, 2023.
With 23166.0 shares estimated at $50710.0 under it, the former controlled 0.02% of total outstanding shares.